share_log

ARS Pharmaceuticals(SPRY.US) 10% Shareholder Buys US$13.29 Million in Common Stock

moomoo News ·  Mar 27 20:18

$ARS Pharmaceuticals (SPRY.US)$ 10% Shareholder RA CAPITAL MANAGEMENT, L.P. purchased 1.4 million shares of Common Stock on Mar 25, 26, 27, 2024 at an average price of $9.48 for a total value of $13.29 million.

This transaction involves other related parties: RA Capital Healthcare Fund LP, RA Capital Nexus Fund II, L.P., Kolchinsky Peter and Shah Rajeev M..

1711585129166425505.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment